5-Chloropyridine-3-boronic acid → HCID 71059652, compound
Reaction equation
Br[C:2]1[CH:3]=[C:4]2[C@@:11]3([C:17]([F:19])([F:18])[CH2:16][O:15][CH2:14][C:13]([NH2:20])=[N:12]3)[CH2:10][CH2:9][O:8][C:5]2=[CH:6][CH:7]=1.[Cl:21][C:22]1[CH:23]=[C:24](B(O)O)[CH:25]=[N:26][CH:27]=1>>[Cl:21][C:22]1[CH:23]=[C:24]([C:2]2[CH:3]=[C:4]3[C@@:11]4([C:17]([F:19])([F:18])[CH2:16][O:15][CH2:14][C:13]([NH2:20])=[N:12]4)[CH2:10][CH2:9][O:8][C:5]3=[CH:6][CH:7]=2)[CH:25]=[N:26][CH:27]=1Participants
3
Procedure
The cross coupling reaction of (R)-6-bromo-6′,6′-difluoro-6′,7′-dihydro-2′H-spiro[chroman-4,5′-[1,4]oxazepin]-3′-amine (intermediate C3.2) with 5-chloropyridin-3-ylboronic acid yielded the title compound (35% yield) as a light brown, amorphous material. MS (ISP): m/z=380.2 [M+H]+.
Sources & evidence
- ORD record
- ord-c79b40c297e84a52be30ecfa42aba585
- Source dataset
- uspto-grants-2015_07
- Patent number
- US09079919B2
Reaction notes
Loading…